plateauing on semaglutide Join our new weight-loss study, PLATEAU! Researchers are studying whether the investigational drug enobosarm can help people lose more weight, compared to a placebo, when combined with semaglutide. We are seeking overweight Why Weight Loss Plateaus on

Instruct patients how to recognize symptoms of low blood pressure and how to reduce the risk of serious consequences should hypotension occur (e.g., sit or lie down, carefully rise from a sitting or lying position) [see WARNINGS]

If the narrow exception applies to you, your physician will explain it at your consult

Mackay-Wiggan, J

Recommended Baseline Tests Comprehensive metabolic panel CBC with differential Thyroid panel (TSH, free T4) Baseline subjective cognitive assessment Blood pressure (Semax can transiently elevate BP) Liver function if using Cerebrolysin long-term Key Safety Notes Semax: may increase irritability at high doses Selank: generally very safe, mild sedation possible Dihexa: extremely potent start low, go slow Noopept: headache common at high doses (choline deficit) Avoid combining multiple BDNF-elevating compounds without guidance Most lack long-term human safety data Frequently Asked Questions Is Semax legal in the US

We monitor your weight loss progress, adjust dosing as needed, address any side effects, and provide nutritional and lifestyle guidance

For adjusted EBITDA, the company expects a range of $14 million to $20 million, up from a prior range of $7 million to $15 million